Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Malaguarnera, M., Pistone, G., Astuto, M., Vecchio, I., Raffaele, R., Lo, Giudice E., and Rampello, L
Prior authorization, required lifestyle programs, step therapy, comorbidity thresholds and narrower formularies are all ways employers try to control who gets access and for how long
Abnormal early cleavage events predict early embryo demise: sperm oxidative stress and early abnormal cleavage
The Phase 2 trial enrolled participants with obesity and evaluated multiple dose levels over 48 weeks: 1 mg dose: 8.7% average body weight reduction 4 mg dose (escalated from 2 mg): 17.1% average body weight reduction 8 mg dose (escalated from 2 mg): 22.8% average body weight reduction 12 mg dose (escalated from 2 mg): 24.2% average body weight reduction Placebo: 2.1% average body weight reduction Those Phase 2 numbers were striking enough
If you dont have one of those conditions but your BMI is between 30 and 34.9, you may qualify if you have chronic kidney disease, uncontrolled high blood pressure (hypertension) or heart failure with preserved ejection fraction
US$ 28.54
US$ 22.08
US$ 21.51
